Abhishek Samanta - Concepedia

Author

Abhishek Samanta

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

A K Samanta, A SAMANTA, A Samanta, A. K. SAMANTA, A. K. Samanta, A. Samanta, A.K. Samanta, Abhishek Samanta, Arunima Samanta, Saha, Aheli

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Indian Institute of Chemical Biology Indian Institute of Management Calcutta Temple University Icahn School of Medicine at Mount Sinai

About

Abhishek Samanta is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	692
2	Cell Biology	7	7	671
3	Engineering	6	6	225
4	Allergy	2	2	230
5	Biostatistics	1	1	126

Abhishek Samanta

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. Abhishek Samanta, Joost J. Oppenheim, Koji Matsushima Journal of Biological Chemistry ImmunologyImmune RegulationImmunologic MechanismImmune SystemImmunotherapy	1990	209
Identification and characterization of specific receptors for monocyte-derived neutrophil chemotactic factor (MDNCF) on human neutrophils. Abhishek Samanta, Joost J. Oppenheim, Kouji Matsushima The Journal of Experimental Medicine Chemokine BiologyInnate Immune SystemImmunologyImmune RegulationInnate Immunity	1989	148
Automated detection of diabetic retinopathy using convolutional neural networks on a small dataset Abhishek Samanta, Aheli Saha, Suresh Chandra Satapathy, Pattern Recognition Letters Diabetic RetinopathyConvolutional Neural NetworkMachine VisionImage AnalysisData Science	2020	126
Jak2 inhibition deactivates Lyn kinase through the SET–PP2A–SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients Abhishek Samanta, Sharmistha Chakraborty, Yingjun Wang, Oncogene Hematological MalignancyReceptor Tyrosine KinaseApoptosisCancer Cell BiologyCell Death	2009	112
Janus kinase 2 regulates Bcr–Abl signaling in chronic myeloid leukemia Abhishek Samanta, Bastianella Perazzona, Sharmistha Chakraborty, Leukemia Hematological MalignancyChronic Myeloid LeukemiaSystems BiologyJak2 ActionMixed-phenotype Acute Leukemia	2010	93
Biophysical properties and molecular characterization of amiloride-sensitive sodium channels in A549 cells Ahmed Lazrak, Abhishek Samanta, Sadis Matalon American Journal of Physiology-Lung Cellular and Molecular Physiology	2000	80
Modification of biophysical properties of lung epithelial Na<sup>+</sup> channels by dexamethasone Ahmed Lazrak, Abhishek Samanta, Kiriaki Venetsanou, American Journal of Physiology-Cell Physiology	2000	77
Destabilization of Bcr-Abl/Jak2 Network by a Jak2/Abl Kinase Inhibitor ON044580 Overcomes Drug Resistance in Blast Crisis Chronic Myelogenous Leukemia (CML) Abhishek Samanta, Soumya Chakraborty, Yongtao Wang, Genes & Cancer Hematological MalignancyChronic Myeloid LeukemiaMedicineMixed-phenotype Acute LeukemiaRespective Jak2	2010	39
Deterministic Blind Rendezvous in Cognitive Radio Networks Sixia Chen, Alexander Russell, Abhishek Samanta, Dynamic Spectrum ManagementCognitive Radio Resource ManagementEngineeringChannel SubsetsDistributed Coordination	2014	37
A Non-ATP-Competitive Dual Inhibitor of JAK2V617F and BCR-ABLT315I Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition Shashi Jatiani, Stephen C. Cosenza, M. V. Ramana Reddy, Genes & Cancer Molecular BiologyCell DeathUnrelated Jak2Tumor BiologyMyeloid Neoplasia	2010	36

Page 1